a developer of anticancer therapies with high safety profiles
Industry Biotechnology
A.I.dvisor tells us that APTO and LCTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTO and LCTX's prices will move in lockstep.
Ticker / NAME | Correlation To APTO | 1D Price Change % | ||
---|---|---|---|---|
APTO | 100% | -4.69% | ||
LCTX - APTO | 31% Poorly correlated | +0.93% | ||
ORMP - APTO | 25% Poorly correlated | +2.13% | ||
ORIC - APTO | 24% Poorly correlated | -6.91% | ||
INBX - APTO | 23% Poorly correlated | -3.16% | ||
BNOX - APTO | 23% Poorly correlated | -4.03% | ||
More |